EcoDrugPlus

Lysine (K)-Specific Demethylase 1a

Ensembl ID : ENSLCAG00010018590
Gene Symbol: KDM1A
1 Cross references
212 Possible Orthologues:

Lysyl Oxidase-Like 2a

Ensembl ID : ENSLCAG00010006863
Gene Symbol: LOXL2A
1 Cross references
190 Possible Orthologues:

Lysyl Oxidase-Like 2a

Ensembl ID : ENSLCAG00010008280
Gene Symbol: LOXL2A
1 Cross references
190 Possible Orthologues:

Lysyl Oxidase-Like 2b

Ensembl ID : ENSLCAG00010027448
Gene Symbol: LOXL2B
1 Cross references
213 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSLCAG00010018445
Gene Symbol: LOC108885537
4 Cross references
229 Possible Orthologues:

Macrophage Stimulating 1 Receptor B

Ensembl ID : ENSLCAG00010018663
Gene Symbol: MST1RB
3 Cross references
193 Possible Orthologues:

Macrophage-Stimulating Protein Receptor

Ensembl ID : ENSLCAG00010008488
Gene Symbol: LOC108889968
3 Cross references
188 Possible Orthologues:

Mast Cell Protease 1-Like

Ensembl ID : ENSLCAG00010010532
Gene Symbol: LOC108877308
3 Cross references
960 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSLCAG00010015037
Gene Symbol: MMP1
2 Cross references
251 Possible Orthologues:

Matrix Metallopeptidase 14a (Membrane-Inserted)

Ensembl ID : ENSLCAG00010000187
Gene Symbol: MMP14A
4 Cross references
198 Possible Orthologues:

Matrix Metallopeptidase 14b (Membrane-Inserted)

Ensembl ID : ENSLCAG00010006807
Gene Symbol: MMP14B
4 Cross references
196 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSLCAG00010016793
Gene Symbol: MMP2
1 Cross references
209 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).